Cargando…

Protective efficacy of intranasal inactivated pseudorabies vaccine is improved by combination adjuvant in mice

Pseudorabies virus (PRV) not only causes great economic loss to the pig industry but also seriously threatens the biosafety of other mammals, including humans. Since 2011, PRV mutant strains have emerged widely in China, and the classical Bartha-K61 vaccine cannot confer complete protection for pigs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hua, Tao, Chang, Chen, Zhang, Xuehua, Huang, Yuqing, Wang, Haiyan, Zhang, Daohua, Tang, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520748/ https://www.ncbi.nlm.nih.gov/pubmed/36187997 http://dx.doi.org/10.3389/fmicb.2022.976220

Ejemplares similares

A single dose of Astragalus saponins adjuvanted inactivated vaccine for pseudorabies virus protected mice against lethal challenge
por: Chang, Chen, et al.
Publicado: (2022)

Pseudorabies gD protein protects mice and piglets against lethal doses of pseudorabies virus
por: Zhao, Mengpo, et al.
Publicado: (2023)

The Inactivated gE/TK Gene-Deleted Vaccine Against Pseudorabies Virus Type II Confers Effective Protection in Mice and Pigs
por: Jin, Yu-Lan, et al.
Publicado: (2022)

Enhanced Immune Responses in Mice Induced by the c-di-GMP Adjuvanted Inactivated Vaccine for Pseudorabies Virus
por: Hou, Liting, et al.
Publicado: (2022)

Glycerol Monolaurate to Ameliorate Efficacy of Inactivated Pseudorabies Vaccine
por: Ren, Qinghai, et al.
Publicado: (2022)

Efficacy of a gB + gD-based subunit vaccine and the adjuvant granulocyte-macrophage colony stimulating factor for pseudorabies virus in rabbits
por: Cao, Zhi, et al.
Publicado: (2022)

Myricetin inhibits pseudorabies virus infection through direct inactivation and activating host antiviral defense
por: Hu, Huaiyue, et al.
Publicado: (2022)

Antigen-Sparing and Enhanced Efficacy of Multivalent Vaccines Adjuvanted with Immunopotentiators in Chickens
por: Wu, Peipei, et al.
Publicado: (2017)

Development of the Inactivated QazCovid-in Vaccine: Protective Efficacy of the Vaccine in Syrian Hamsters
por: Zhugunissov, Kuandyk, et al.
Publicado: (2021)

The Immunity Protection of Central Nervous System Induced by Pseudorabies Virus DelgI/gE/TK in Mice
por: Xu, Lei, et al.
Publicado: (2022)

An inactivated gE-deleted pseudorabies vaccine provides complete clinical protection and reduces virus shedding against challenge by a Chinese pseudorabies variant
por: Wang, Jichun, et al.
Publicado: (2016)

Progress on innate immune evasion and live attenuated vaccine of pseudorabies virus
por: Nie, Zhenyu, et al.
Publicado: (2023)

Shape-dependent adjuvanticity of nanoparticle-conjugated RNA adjuvants for intranasal inactivated influenza vaccines
por: Tazaki, Taiyu, et al.
Publicado: (2018)

Intranasal Immunization Using Mannatide as a Novel Adjuvant for an Inactivated Influenza Vaccine and Its Adjuvant Effect Compared with MF59
por: Ren, Shu-Ting, et al.
Publicado: (2017)

The Cytoprotective Enzyme Heme Oxygenase-1 Suppresses Pseudorabies Virus Replication in vitro
por: Zhang, Angke, et al.
Publicado: (2020)

The Immune Efficacy of Inactivated Pseudorabies Vaccine Prepared from FJ-2012ΔgE/gI Strain
por: Chen, Qiu-Yong, et al.
Publicado: (2022)

Evasion of I Interferon-Mediated Innate Immunity by Pseudorabies Virus
por: Zhang, Rui, et al.
Publicado: (2021)

Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs
por: Dhakal, Santosh, et al.
Publicado: (2018)

Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against reindeer rabies
por: Matveeva, Irina, et al.
Publicado: (2022)

Cytokines: The Future of Intranasal Vaccine Adjuvants
por: Thompson, Afton L., et al.
Publicado: (2011)

Simultaneous Intramuscular And Intranasal Administration Of Chitosan Nanoparticles–Adjuvanted Chlamydia Vaccine Elicits Elevated Protective Responses In The Lung
por: Li, Yumeng, et al.
Publicado: (2019)

(−)-Epigallocatechin-3-Gallate Inhibits the Life Cycle of Pseudorabies Virus In Vitro and Protects Mice Against Fatal Infection
por: Huan, Changchao, et al.
Publicado: (2021)

Inactivation Performance of Pseudorabies Virus as African Swine Fever Virus Surrogate by Four Commercialized Disinfectants
por: Ni, Zheng, et al.
Publicado: (2023)

Intranasal administration with recombinant Bacillus subtilis induces strong mucosal immune responses against pseudorabies
por: Wang, Jialu, et al.
Publicado: (2019)

Evaluation of Immunoreactivity and Protection Efficacy of Seneca Valley Virus Inactivated Vaccine in Finishing Pigs Based on Screening of Inactivated Agents and Adjuvants
por: Liu, Wenqiang, et al.
Publicado: (2022)

Pseudorabies virus exploits N(6)-methyladenosine modification to promote viral replication
por: Yu, Pei-Lun, et al.
Publicado: (2023)

Intranasal Vaccination with Mannosylated Chitosan Formulated DNA Vaccine Enables Robust IgA and Cellular Response Induction in the Lungs of Mice and Improves Protection against Pulmonary Mycobacterial Challenge
por: Wu, Manli, et al.
Publicado: (2017)

Establishment of a Fosmid Library for Pseudorabies Virus SC Strain and Application in Viral Neuronal Tracing
por: Qi, Hansong, et al.
Publicado: (2020)

Epidemiological and genetic characteristics of swine pseudorabies virus in mainland China between 2012 and 2017
por: Sun, Ying, et al.
Publicado: (2018)

The Fluoroquinolone Finafloxacin Protects BALB/c Mice Against an Intranasal Infection With Francisella tularensis Strain SchuS4
por: Barnes, Kay B., et al.
Publicado: (2019)

Meclizine Inhibits Pseudorabies Virus Replication by Interfering With Virus Entry and Release
por: Liu, Panrao, et al.
Publicado: (2021)

Resveratrol Inhibits Pseudorabies Virus Replication by Targeting IE180 Protein
por: Chen, Xiangxiu, et al.
Publicado: (2022)

Vesicular Stomatitis Virus-Vectored Multi-Antigen Tuberculosis Vaccine Limits Bacterial Proliferation in Mice following a Single Intranasal Dose
por: Zhang, Ming, et al.
Publicado: (2017)

Bacillus subtilis vector based oral rabies vaccines induced potent immune response and protective efficacy in mice
por: Zhang, Ying, et al.
Publicado: (2023)

MERS-CoV Spike Protein Vaccine and Inactivated Influenza Vaccine Formulated with Single Strand RNA Adjuvant Induce T-Cell Activation through Intranasal Immunization in Mice
por: Kim, Hye-Jung, et al.
Publicado: (2020)

Monophosphoryl-Lipid A (MPLA) is an Efficacious Adjuvant for Inactivated Rabies Vaccines
por: Chen, Chen, et al.
Publicado: (2019)

Intranasal Immunization with DnaK Protein Induces Protective Mucosal Immunity against Tuberculosis in CD4-Depleted Mice
por: Chuang, Yu-Min, et al.
Publicado: (2018)

Quillaja brasiliensis nanoparticle adjuvant formulation improves the efficacy of an inactivated trivalent influenza vaccine in mice
por: Silveira, Fernando, et al.
Publicado: (2023)

Inactivated vaccine with glycyrrhizic acid adjuvant elicits potent innate and adaptive immune responses against foot-and-mouth disease
por: Shin, Seokwon, et al.
Publicado: (2023)

The efficacy of a 2,4-diaminoquinazoline compound as an intranasal vaccine adjuvant to protect against influenza A virus infection in vivo
por: Noh, Kyungseob, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_440fger4c4o9sjiu4krjfvg7t4